Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 9, 2017) - NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Pascal Biosciences...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 30, 2017) - NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES bioMmune...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 20, 2016) - NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES bioMmune...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 29, 2016) - bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE:IMU) has been awarded its first patent for monoclonal...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 22, 2016) - BioMmune Technologies Inc. ("BioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 9, 2015) - bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 19, 2015) - BioMmune Technologies Inc. ("Biommune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 11, 2015) - BioMmune Technologies Inc. (the "Company") (TSX VENTURE:IMU), announces a non-brokered private placement of up to 2,000,000...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 4, 2015) - BioMmune Technologies Inc. (TSX VENTURE:IMU) (the "Company") is pleased to announce that pursuant to the Company's Incentive...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 30, 2015) - BioMmune Technologies Inc., (TSX VENTURE:IMU) (the "Company") is pleased to announce the appointment of Mr. Jens Biertumpel as...